Literature DB >> 22329349

Richter transformation in 16 of 149 Chinese patients with chronic lymphocytic leukemia.

Lei Fan1, Li Wang, Run Zhang, Cheng Fang, Dan-Xia Zhu, Yin-Hua Wang, Zhi-Jian Zou, Jian-Yong Li, Wei Xu.   

Abstract

No confirmed risk factors are known to predict Richter syndrome (RS), and the value of clinical prognosticators conventionally applied to chronic lymphocytic leukemia (CLL) is not firmly established in this setting. The objective of this study was to present evidence for RS in Chinese patients with CLL and risk factors for CLL transformation to Richter syndrome. With a median follow-up of 43 months from CLL diagnosis in 149 Chinese patients, 16 (10.7%) patients progressed to diffuse large B-cell lymphoma (DLBCL). According to correlation analysis, a high level of lactate dehydrogenase (LDH) and CD38 positivity were found to be independent predictors of transformation to RS. Survival analysis showed that presence of RS, advanced Binet stage, high level of LDH, high level of β(2)-microglobulin, high concentration of thymidine kinase (TK), ZAP-70 and CD38 expression, unmutated immunoglobulin heavy chain variable (IGHV) gene status and del(17p13) were adverse factors in determining overall survival (OS). Only del(17p13) was strongly associated with survival by multivariate Cox regression analysis. Median OS after transformation was 16 months (95% confidence interval, 5.6-26.4 months). The results support that RS is associated with a poor outcome, and a policy of close monitoring and careful biopsy is needed in patients carrying transformation risk factors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22329349     DOI: 10.3109/10428194.2012.664845

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  10 in total

1.  How we treat Richter syndrome.

Authors:  Sameer A Parikh; Neil E Kay; Tait D Shanafelt
Journal:  Blood       Date:  2014-01-13       Impact factor: 22.113

Review 2.  Risk factors for Richter syndrome in chronic lymphocytic leukemia.

Authors:  Sameer A Parikh; Tait D Shanafelt
Journal:  Curr Hematol Malig Rep       Date:  2014-09       Impact factor: 3.952

3.  Richter's transformation presenting as splenic rupture after 6 years of complete remission of chronic lymphocytic leukaemia.

Authors:  Braghadheeswar Thyagarajan; Sayee Sundar Alagusundaramoorthy; Lopa Shah; Abhinav Agrawal
Journal:  BMJ Case Rep       Date:  2016-06-10

4.  Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients.

Authors:  Sameer A Parikh; Kari G Rabe; Timothy G Call; Clive S Zent; Thomas M Habermann; Wei Ding; Jose F Leis; Susan M Schwager; Curtis A Hanson; William R Macon; Neil E Kay; Susan L Slager; Tait D Shanafelt
Journal:  Br J Haematol       Date:  2013-07-11       Impact factor: 6.998

5.  Diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia: A single center experience.

Authors:  Ajay Gogia; Vinod Raina; Lalit Kumar; Atul Sharma; Prashant Mehta; Mehar Chander Sharma
Journal:  South Asian J Cancer       Date:  2014-07

6.  The Occurrence of Richter's Syndrome during Treatment with Obinutuzumab and Chlorambucil.

Authors:  Teng Fong Ng; Benedict Carnley; Celia Green; Dominic Spagnolo; Michael F Leahy
Journal:  Case Rep Hematol       Date:  2020-07-16

7.  Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center.

Authors:  Yucai Wang; Marcella A Tschautscher; Kari G Rabe; Timothy G Call; Jose F Leis; Saad S Kenderian; Neil E Kay; Eli Muchtar; Daniel L Van Dyke; Amber B Koehler; Susan M Schwager; Susan L Slager; Sameer A Parikh; Wei Ding
Journal:  Haematologica       Date:  2019-06-13       Impact factor: 9.941

8.  CARD9 Forms an Alternative CBM Complex in Richter Syndrome.

Authors:  Julia Maier; André Lechel; Ralf Marienfeld; Thomas F E Barth; Peter Möller; Kevin Mellert
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

9.  [The guidelines for diagnosis and treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma in China (2018 edition)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2018-05-14

10.  [The relationship between NOTCH1 mutation and the Richter transformation in chronic lymphocytic leukemia].

Authors:  X L Chen; S F Wang; Z S Xu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2018-09-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.